Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of desloratadine compound in preparing information medicine, preparation method and prepared novel drug

A chemotherapeutic drug, the technology of dilotadine, applied in the field of medicine, can solve tiredness, headache, nausea, drowsiness, forgetfulness, edema, heartbeat, tachycardia, palpitations, elevated liver enzymes, increased bilirubin, restriction Treatment effect, non-secondary application, etc., to reduce the cost of treatment, overcome side effects, and increase the value of use

Inactive Publication Date: 2012-07-25
北京中卫神农慢性病医学研究院有限公司
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In the prior art, desloratadine has insurmountable defects as a chemotherapeutic drug, the first is the toxic and side effects on the human body, and its unpleasant adverse reactions include dry mouth, tiredness, headache, nausea, lethargy , forgetfulness, edema, heartbeat, tachycardia, palpitations, elevated liver enzymes, increased bilirubin, etc.; second, the treatment window is small. Due to the toxic and side effects on the human body, the effective dose that can be used is very small, which limits the therapeutic effect. The maximum dose of oral administration is 5 mg once and 5 mg per day. If the maximum dose is exceeded, it can cause poisoning; the third is that there is only one use of chemotherapy drugs, and the drugs will be metabolized or excreted when they enter the human body, so they cannot be used for the second time.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of desloratadine compound in preparing information medicine, preparation method and prepared novel drug
  • Application of desloratadine compound in preparing information medicine, preparation method and prepared novel drug
  • Application of desloratadine compound in preparing information medicine, preparation method and prepared novel drug

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0044] Take the desloratadine raw material (1) by the following weight: 400 grams of the desloratadine raw material (1) (content ≥ 99%), put the raw material (1) into the filling machine, and use a microporous air-permeable paper bag according to the net weight of 10 per bag. Pack into 40 bags by gram, and heat-melt and seal to make desloratadine drug information packing bag (3). Simultaneously, make magnetic suspension (card) (8) container (4) box 40 in addition. The manufacturing method of the magnetic suspension (card) (8) container (4) box is: use plastic mold injection molding to produce an oblate container (4) box with an inner hollow diameter of 5-10cm and a height of 0.5-1.5cm, and the container (4) box A number of holes (5) with a diameter of 0.1 cm are placed on the outside of the lower part, and a magnetic sheet (7) with a magnetic force of 500-1500 Gauss is placed on the concave surface of the top of the container (4), and a magnetic sheet (7) of the same size is a...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
particle diameteraaaaaaaaaa
diameteraaaaaaaaaa
Login to View More

Abstract

The invention discloses application of a desloratadine compound in preparing an information medicine, a preparation method of the information medicine by the desloratadine compound and a novel drug prepared by the preparation method. During the treatment, the information medicine does not directly touch a human body, drug substance components are not consumed, chemotherapy effects can be achieved only by utilizing drug information physiotherapy, and the therapy window is enlarged by more than one thousand times, and side effects of the chemotherapy are avoided. After desloratadine is used as the information treatment drug, the effective component content is not changed, and desloratadine can be used secondarily and effectively as a chemotherapy normal preparation.

Description

technical field [0001] The invention relates to the field of medicines, in particular to a novel drug of desloratadine. Background technique [0002] Compound desloratadine (Desloratadine), chemical name: 8-chloro-6,11-dihydro-11-(4-piperidinylidene)-5H-benzo[5,6]arhepta[1,2 -b] pyridine, chemical formula C 19 h 19 ClN 2 , molecular weight 310.82. Appearance is white crystalline powder. Desloratadine is an antiallergic drug, clinically used for the treatment of allergic diseases. The pharmaceutical preparations of desloratadine include tablets, capsules and the like. The known desloratadine drugs are all used as chemotherapeutic drugs, which allow the compound desloratadine molecules to enter the human body (through oral absorption into the blood), distribute to various tissues, and produce chemical reactions through the drug molecules in the human body. pharmacological effects. In the prior art, desloratadine has insurmountable defects as a chemotherapeutic drug, th...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/4545A61K47/02A61P37/08A61M37/00
Inventor 杨孟君杨哲
Owner 北京中卫神农慢性病医学研究院有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products